Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) rose 19.3% on Friday . The stock traded as high as GBX 1.70 and last traded at GBX 1.67. Approximately 619,121 shares changed hands during trading, an increase of 39% from the average daily volume of 444,710 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Stock Up 21.4%
The company has a quick ratio of 4.66, a current ratio of 0.48 and a debt-to-equity ratio of -54.35. The company has a fifty day simple moving average of GBX 1.51 and a 200-day simple moving average of GBX 1.54. The firm has a market cap of £6.74 million, a P/E ratio of -5.31 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than Cizzle Biotechnology
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump Planning to Use Public Law 63-43: Prepare Now
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Elon Musk: This Could Turn $100 into $100,000
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
